Aharon Schwartz, Director at Foamix Pharmaceuticals Ltd. (FOMX), bought 112,200 shares at $3.89 ($438K) on 2018-11-26, disclosed to the SEC on 2018-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.89 | 50,000 | $195K | 44.4% |
| 2 | $3.92 | 50,000 | $196K | 44.8% |
| 3 | $3.88 | 12,200 | $47K | 10.8% |
| Total | $3.90 avg | 112,200 | $438K | 100% |
| Filing → |
| PLX | BUY | 2020-04-13 | $156K | — | Filing → |